CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 192 enrolled
Drug / intervention
AMPLATZER Duct Occluder IIdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00713700
NCT00713700N/ACompleted
CompareCT.gov

Closure of Patent Ductus Arteriosus With the AMPLATZER DUCT Occluder II

Abbott Medical Devices·interventional·Posted Jul 11, 2008·Updated Feb 4, 2019

In Brief

A clinical study evaluating AMPLATZER Duct Occluder II for Patent Ductus Arteriosus. Completed, enrolled 192 participants across 25 sites.

Detailed Summary

The objective of this study is to investigate the safety and effectiveness of the ADO II in patients with a PDA.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPatent Ductus Arteriosus
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 11, 2008
Enrollment StartAug 1, 2008
Primary CompletionOct 1, 2011
Study CompletionOct 5, 2016
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 18.0 years ago

Interventions

AMPLATZER Duct Occluder IIdevice

AMPLATZER Duct Occluder II